Michael Fishman, MD
Interventional Pain Medicine · Lebanon, PANPI 1841429156
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $430,134 of the $670,131 with a category attached, or 64.2%. Medtronic accounts for 80.4% of it on its own, with 52 other manufacturers making up the rest. Reporting peaked in 2022 at $229,016 and has fallen 97.8% since, to $4,960 in 2025. Among interventional pain medicine clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,349 payments — averaging $496.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$539K
- Aurora Spine, Inc.$46K
- MML US, Inc.$29K
- Nevro Corp.$22K
- Abbott$13K
- Collegium Pharmaceutical, Inc.$5K
- plus $16K from 47 others
Across 330 payments — averaging $2666.72 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$717K
- Abbott$85K
- MML US, Inc.$49K
- Biotronik Inc.$12K
- Vertiflex, Inc.$7K
- Nalu Medical, Inc.$7K
- plus $3K from 2 others
What the payments were for
- Royalty or licence$21,2663%
- Consulting fees$105,05016%
- Speaking & faculty fees$430,13464%
- Travel & lodging$81,26312%
- Food & beverage$32,3595%
- Education$600%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$230,119
- INTELLIS$148,622
- ZIP$46,420
- VANTA ADAPTIVESTIM$39,292
- ReActiv8$27,656
- RESTORE$26,382
- ADAPTIVESTIM$21,684
- Senza Spinal Cord Stimulation System$21,075
- SYNCHROMED$11,620
- Proclaim Family of SCS IPGs$7,672
- XTAMPZA$4,276
- BELBUCA$4,170
- Intracept$3,196
- Neuromodulation Dspsbls and Accs$3,033
- OPTIMIZER$2,709
- RESTORESENSORSURESCAN$2,573
- Inflate FX$2,450
- Prospera$2,017
- Vanta$1,287
- mild Device Kit$1,225
How this compares
$670,131 in reported general payments places this provider in the 95th percentile of 59 interventional pain medicine providers in Pennsylvania.
See all interventional pain medicine providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 59 | $1,099 |
| Morphine Sulfate ErMorphine Sulfate | 16 | $458 |
| Gabapentin | 33 | $272 |
| Methadone Hcl | 13 | $196 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $190 |
| Tramadol Hcl | 19 | $62 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Lebanon
- David ProvenzanoSewickley$198K
- Michael FarrellPittsburgh$23K
- Farshad RashidianWest Chester$19K
- Chad MetzgerDarby$14K
- Jorge Rivero-BecerraPittsburgh$12K
- James BresnahanSpringfield$12K
- Jonathan SchollIndiana$11K
- Nathan MaltezosWest Chester$10K
- Mark BellPlains$9K
- Danish QureshiPittsburgh$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.